d(CH2)5[D-Ile2,Ile4]AVP [2773]
d(CH2)5[D-Ile2,Ile4]AVP
| SMILES |
CC[C@@H](C)[C@@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](NC(=O)CC1CCCCC1=S)[C@@H](C)CC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CS)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCN=C(N)N)C(=O)NCC(N)=O |
| InChIKey |
CNWFVLCMGVAHSD-HAEBMLOOSA-N |
| Sequence |
XIFINCPRG |
Chemical Properties
| Hydrogen bond acceptors |
13 |
| Hydrogen bond donors |
12 |
| Rotatable bonds |
30 |
| Log P |
-1.368 |
| Molecular weight (Da) |
1071.5 |
| Stereochemistry info |
partial |
Bioactivities
|
| Receptor |
Activity |
Source |
| Protein |
Gene |
Species |
Family |
Class |
Type |
Min |
Avg |
Max |
Database |
|
|
|
|
|
|
|
|
|
|
|
| Receptor |
Activity |
Source |
| Protein |
Gene |
Species |
Family |
Class |
Type |
Min |
Avg |
Max |
Database |
|
|
|
|
|
|
|
|
|
|
Drug properties
| Molecular type |
Peptide |
| Physiological/Surrogate |
Surrogate |
| Approved drug |
No |
Distribution across phases (no. indications)
Phase I
0
Phase II
0
Phase III
0
Phase IV
0
Compound is not listed as a drug.